Time in Range (TIR), a new statistic introduced by CGM systems. It measures how long a person's blood glucose levels remain within a particular range. According to Professor Kar, TIR provides "a ...

Fourteen-day continuous glucose monitoring (CGM) traces added to Diabetes Control and Complications Trial (DCCT) data can predict microvascular diabetes complications similarly to glycated hemoglobin.

This study reinforces the significance of intensive glycaemic control and is a paradigm shift in managing the disease and its complications.

Time in range was similar among pediatric patients with type 1 diabetes who used either the Insulet Omnipod 5 or the Tandem Control IQ.

However, the use of continuous glucose monitoring is on the rise and ... These readings included the time spent in "tight range" (between 70 and 140 mg/DL) as well as the time spent above 140 ...

China: A new study published in Diabetes, Obesity and Metabolism has highlighted the significant role of tight glycemic ...

Adults with insulin-treated type 2 diabetes had a significant HbA1c decline at 13 weeks with use of the Omnipod 5 automated ...